Predicting the Gene Status and Survival Outcome of Lower Grade Glioma Patients With Multimodal MRI Features

by Ahmad Chaddad, Christian Desrosiers, Bassam Abdulkarim, Tamim Niazi
Published 2019-01-01

Integration of Radiomic and Multi-omic Analyses Predicts Survival of Newly Diagnosed IDH1 Wild-Type Glioblastoma

by Ahmad Chaddad, Paul Daniel, Siham Sabri, Christian Desrosiers, Bassam Abdulkarim
Published 2019-08-01

Radiomics in Glioblastoma: Current Status and Challenges Facing Clinical Implementation

by Ahmad Chaddad, Michael Jonathan Kucharczyk, Paul Daniel, Siham Sabri, Siham Sabri, Bertrand J. Jean-Claude, Bertrand J. Jean-Claude, Tamim Niazi, Bassam Abdulkarim, Bassam Abdulkarim
Published 2019-05-01

Spontaneous epithelial-mesenchymal transition and resistance to HER-2-targeted therapies in HER-2-positive luminal breast cancer.

by David Lesniak, Siham Sabri, Yaoxian Xu, Kathryn Graham, Pravin Bhatnagar, Mavanur Suresh, Bassam Abdulkarim
Published 2013-01-01

SABR-BRIDGE: Stereotactic ABlative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG Cancer or OligomEts During the COVID-19 Pandemic

by Biniam Kidane, Biniam Kidane, Biniam Kidane, Jonathan Spicer, Jonathan Spicer, Julian O. Kim, Julian O. Kim, Pierre-Olivier Fiset, Bassam Abdulkarim, Richard Malthaner, Richard Malthaner, David Palma, David Palma
Published 2020-09-01

An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy

by Cedric Darini, Nour Ghaddar, Catherine Chabot, Gloria Assaker, Siham Sabri, Shuo Wang, Jothilatha Krishnamoorthy, Marguerite Buchanan, Adriana Aguilar-Mahecha, Bassam Abdulkarim, Jean Deschenes, Jose Torres, Josie Ursini-Siegel, Mark Basik, Antonis E. Koromilas
Published 2019-05-01

Cleavage of the extracellular domain of junctional adhesion molecule-A is associated with resistance to anti-HER2 therapies in breast cancer settings

by Astrid O. Leech, Sri HariKrishna Vellanki, Emily J. Rutherford, Aoife Keogh, Hanne Jahns, Lance Hudson, Norma O’Donovan, Siham Sabri, Bassam Abdulkarim, Katherine M. Sheehan, Elaine W. Kay, Leonie S. Young, Arnold D. K. Hill, Yvonne E. Smith, Ann M. Hopkins
Published 2018-11-01

Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non‐small cell lung cancer (NSCLC) through inhibition of HIF‐1α

by Olga‐Demetra Biziotis, Evangelia Evelyn Tsakiridis, Amr Ali, Elham Ahmadi, Jianhan Wu, Simon Wang, Bassem Mekhaeil, Kanwaldeep Singh, Gabe Menjolian, Thomas Farrell, Bassam Abdulkarim, Ranjan K. Sur, Aruz Mesci, Peter Ellis, Tobias Berg, Jonathan L Bramson, Paola Muti, Gregory R Steinberg, Theodoros Tsakiridis
Published 2023-11-01